Glucocorticoid toxicity index

The Glucocorticoid Toxicity Index (GTI) is a glucocorticoid-related toxicity measurement tool which was recently developed by an international expert panel. GTI can be calculated with two different methods: Cumulative Worsening Score (CWS) and Aggregate Improvement Score (AIS). The total glucocorticoid-related toxicity during follow-up can be calculated with CWS. All parameters that develop over time continue to be included, and a decrease in the CWS is not possible. On the contrary, both increase and decrease in toxicity can be assessed in scoring with the AIS method. A drug that reduces glucocorticoid toxicity should be able to reduce the AIS score. Cumulative glucocorticoid dose was found to be associated with higher GTI scores in studies. Although not all glucocorticoid-related toxicities can be covered, parameters that are common, dynamic, and more likely to be glucocorticoid-related are included in GTI. GTI has some limitations such as the possibility of not detecting chronic damage, the difficulty in interpreting the score in the patients who have already sterted the glucocorticoid treatment, some parameters requiring direct interaction with the patient, and difficulty in calculation.

Authors

Institutions

Publication Details

Journal
Acta Medica
Published
2024-12-03
DOI
https://doi.org/10.32552/2024.actamedica.1098
Primary Topic
Adrenal Hormones and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Glucocorticoid toxicity index

Melda Bahap, Sema Kaymaz‐Tahra
Acta Medica
Adrenal Hormones and Disorders
article

Glucocorticoid toxicity index

Melda Bahap, Sema Kaymaz‐Tahra
article en

Abstract

The Glucocorticoid Toxicity Index (GTI) is a glucocorticoid-related toxicity measurement tool which was recently developed by an international expert panel. GTI can be calculated with two different methods: Cumulative Worsening Score (CWS) and Aggregate Improvement Score (AIS). The total glucocorticoid-related toxicity during follow-up can be calculated with CWS. All parameters that develop over time continue to be included, and a decrease in the CWS is not possible. On the contrary, both increase and decrease in toxicity can be assessed in scoring with the AIS method. A drug that reduces glucocorticoid toxicity should be able to reduce the AIS score. Cumulative glucocorticoid dose was found to be associated with higher GTI scores in studies. Although not all glucocorticoid-related toxicities can be covered, parameters that are common, dynamic, and more likely to be glucocorticoid-related are included in GTI. GTI has some limitations such as the possibility of not detecting chronic damage, the difficulty in interpreting the score in the patients who have already sterted the glucocorticoid treatment, some parameters requiring direct interaction with the patient, and difficulty in calculation.

Acta MedicaVol. 55
Bahçeşehir University (TR), Hacettepe University (TR)
Good health and well-being
Openalex Percentile: Top 66%
Adrenal Hormones and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Glucocorticoid toxicity index — Melda Bahap, Sema Kaymaz‐Tahra · Acta Medica (2024) | TGRS Research Map | TGRS